Form 4: Baxter International Director David S. Wilkes Reports Acquisition of Common Stock

Director David S. Wilkes reports acquiring 5,952 shares of Baxter International Inc. common stock on May 7, 2024.

Summary

• On May 7, 2024, David S. Wilkes, a director of Baxter International Inc., acquired 5,952 shares of common stock.
• The acquisition was a grant of fully vested shares.
• The price per share was $0.
• Following the transaction, Wilkes beneficially owns 16,274 shares of Baxter International Inc. common stock, which includes automatic reinvestment of dividends.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director. The acquisition itself can be seen as mildly positive, but the document is primarily informational.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Comparison to Industry Standards

• Monitoring insider transactions is a common practice in financial analysis.
• Comparing the trading activity of Baxter's directors to those of similar companies like Medtronic (MDT) or Johnson & Johnson (JNJ) can provide insights into the overall sentiment surrounding the stock.

Stakeholder Impact

• The acquisition of shares by a director may have a slightly positive impact on shareholder sentiment.

Key Dates